These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35345687)

  • 1. Aggressive Natural Killer Cell Leukemia: A Brief Overview of Its Genomic Landscape, Histological Features, and Current Management.
    Sumbly V; Vest M; Landry I
    Cureus; 2022 Feb; 14(2):e22537. PubMed ID: 35345687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
    Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
    J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Suzuki R
    Int J Hematol; 2010 Dec; 92(5):697-701. PubMed ID: 21116747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive natural killer cell leukemia: diagnosis, treatment recommendations, and emerging therapies.
    Zhang Y; Lee D; Gesiotto Q; Sokol L
    Expert Rev Hematol; 2021 Aug; 14(8):731-740. PubMed ID: 34263714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
    Ishida F; Ko YH; Kim WS; Suzumiya J; Isobe Y; Oshimi K; Nakamura S; Suzuki R
    Cancer Sci; 2012 Jun; 103(6):1079-83. PubMed ID: 22360679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.
    Suzuki R
    Curr Oncol Rep; 2012 Oct; 14(5):395-402. PubMed ID: 22639106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability.
    Kim SM; Park S; Oh DR; Ahn YC; Ko YH; Kim SJ; Kim WS
    Ann Hematol; 2016 Mar; 95(4):581-91. PubMed ID: 26729202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Oh D; Ahn YC; Kim SJ; Kim WS; Ko YH
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):677-83. PubMed ID: 26461010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
    Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G
    J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia.
    Li C; Tian Y; Wang J; Zhu L; Huang L; Wang N; Xu D; Cao Y; Li J; Zhou J
    Transl Res; 2014 Jun; 163(6):565-77. PubMed ID: 24524877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
    Ko YH; Park S; Kim K; Kim SJ; Kim WS
    Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review.
    Yang R; Ai Y; Liu C; Lu X
    Front Pediatr; 2022; 10():829927. PubMed ID: 35676895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive natural killer cell leukemia with skin manifestation associated with hemophagocytic lymphohistiocytosis: A case report.
    Peng XH; Zhang LS; Li LJ; Guo XJ; Liu Y
    World J Clin Cases; 2021 Dec; 9(34):10708-10714. PubMed ID: 35005005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
    Ichikawa S; Fukuhara N; Yamamoto J; Suzuki M; Nakajima S; Okitsu Y; Kohata K; Onishi Y; Ishizawa K; Kameoka J; Harigae H
    Intern Med; 2010; 49(17):1907-10. PubMed ID: 20823655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab in newly diagnosed EBV-negative extranodal natural killer/T-cell lymphoma: A case report.
    Asif S; Begemann M; Bennett J; Fatima R; Masood A; Raza S
    Mol Clin Oncol; 2019 Mar; 10(3):397-400. PubMed ID: 30847181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic stem cell transplantation for aggressive NK cell leukemia].
    Fujimoto A
    Rinsho Ketsueki; 2021; 62(5):360-368. PubMed ID: 34108314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
    Park JA; Jun KR; Nam SH; Ghim TT
    Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
    Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
    Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
    Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.